11:01 AM EDT, 05/22/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts fell Wednesday morning, declining 0.48% to 1,423.09 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company Genfit ( GNFT ) and biotech firm BioNTech (BNTX), which climbed 11% and 6.1% respectively. They were followed by hotel booking site trivago (TRVG) and pharmaceutical company Ascendis Pharma ( ASND ) , which increased 4.5% and 4.1% respectively.

The decliners from continental Europe were led by biopharmaceutical company Grifols ( GRFS ) and semiconductor company Sequans Communications ( SQNS ) , which fell 5.6% and 2.9% respectively. They were followed by biotech firm Evaxion Biotech ( EVAX ) and kidney dialysis company Fresenius Medical Care ( FMS ) , which were down 2.7% and 2.2% respectively.

From the UK and Ireland, the gainers were led by biotech firm Trinity Biotech ( TRIB ) and biopharmaceutical company Bicycle Therapeutics ( BCYC ) , which rose 4.9% and 2.3% respectively. They were followed by biopharmaceutical company Verona Pharma ( VRNA ) and pharmaceutical company GSK (GSK), which were up 2% and 1.6% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) , which plunged 41%, followed by biopharmaceutical company Mereo BioPharma Group ( MREO ) and mining company BHP Group ( BHP ) , which were down 3.3% and 3.4% respectively. They were followed by pharmaceutical company Silence Therapeutics ( SLN ) , which dropped 3%.